ArticleBMC medical genomics2021

HELLS serves as a poor prognostic biomarker and its downregulation reserves the malignant phenotype in pancreatic cancer.

Feng-Jiao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.